Raghavendra Rao: The Link Between Neuropathy and Chronic Venous Disease
Raghavendra Rao, General Surgeon at Vein Clinic, Founder of Best Surgical Education, LLC, shared a post on LinkedIn about a recent article by Vritika Ravisangar et al, published in Journal of Vascular Surgery: Venous and Lymphatic Disorders, adding:
”I have had several patients present to me with neuropathy-like symptoms but without a known cause for the neuropathy. On duplex testing, they had venous reflux.
A recent review shows possible relationship between neuropathy and chronic venous disease. They show clinical correlation as well as mechanistic evidence.
We need more awareness regarding this relationship (even in patients who have diabetes or other causes for their neuropathy) and studies showing the efficacy of endovenous ablation in treating these symptoms.
Personally, I know this is an under-recognized issue, and endovenous ablation has been effective in such patients.”
Title: A Systematic Review Exploring the link between Chronic Venous Disease and Neuropathy
Authors: Vritika Ravisangar, Jessica Bowie, Marwah Salih, Matthew Tan, Rachel Low, Sarah Onida, Alun H. Davies

Stay updated with Hemostasis Today.
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation
-
Aug 26, 2026, 16:18Sam Mbunya: Celebrating Cyrus Njuguna Githinji’s New Leadership Role in Haemophilia Care
-
Aug 26, 2026, 15:48Melissa Hollo: Postpartum Depression is More Than the “Baby Blues”
-
Aug 26, 2026, 15:43Laurent Bertoletti: Long Term Benefits and Safety of Rehabilitation in Pulmonary Arterial Hypertension
-
Aug 26, 2026, 15:41Tamer Hellou: Chromosome 1q Gain Signals High Long-Term Risk in AL Amyloidosis
-
Aug 26, 2026, 15:04Sequential Efgartigimod and Eltrombopag Achieve Durable Response in Refractory ITP – Platelets Journal